All In Biotech

Free tool

FAERS Monitor: Posfrea

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203050 or its brand name (Posfrea, Palonosetron Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

3,601

Serious

3,304

92% of reports

Hospitalization

1,783

Death reported

566

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea443
  • diarrhoea264
  • fatigue264
  • vomiting263
  • febrile neutropenia259
  • neutropenia254
  • alopecia229
  • anaemia203
  • dyspnoea201
  • off label use201
  • decreased appetite191
  • death190
  • pyrexia176
  • asthenia158
  • constipation156

Reports by year received

View as table
YearReports
20047
200521
200613
200718
200828
200924
201027
201138
2012101
201369
2014120
2015159
2016170
2017189
2018322
2019244
2020207
2021317
2022325
2023282
2024287
2025393
2026240

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,558 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal25922.920.45,396
neutropeniaSignal25410.99.72,292
alopeciaSignal2296.86.01,140
anaemiaSignal2036.25.4892
decreased appetiteSignal1914.84.2578
constipationSignal1564.23.6378
nauseaSignal4433.33.0723
vomitingSignal2633.32.9421
pyrexiaSignal1763.02.6232
astheniaSignal1582.52.1137
diarrhoeaSignal2642.42.1219
dyspnoeaSignal2012.11.8114
fatigue2642.01.8132
off label use2011.31.218
death1901.31.112

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.